The Southern California Regional Gamma Knife Center (Tables)

9 Months Ended

Sep. 30, 2020

Neuro Partners LLC and CGK [Member]

Schedule of Equity Method Investments [Line Items]

Equity Method Investment Summarized Financial Information

The following tables present the aggregation of summarized financial information of NeuroPartners LLC and CGK:

NeuroPartners LLC and CGK Condensed Combined Income Statement Information

	Nine Months Ended September 30, (Unaudited)
	2020		2019
Patient Revenue	$	944,000	$	767,000
Net income	$	402,000	$	254,000
USNC's equity in earnings of NeuroPartners LLC and CGK	$	134,000	$	80,000

	Three Months Ended September 30, (Unaudited)
	2020		2019
Patient Revenue	$	274,000	$	278,000
Net income	$	70,000	$	107,000
USNC's equity in earnings of NeuroPartners LLC and CGK	$	23,000	$	35,000

NeuroPartners LLC and CGK Condensed Combined Balance Sheet Information

	September 30, 2020		December 31, 2019
	(Unaudited)
Current assets	$	534,000	$	163,000
Noncurrent assets		615,000		807,000
Total assets	$	1,149,000	$	970,000
Current liabilities	$	750,000	$	380,000
Noncurrent liabilities		-		593,000
Equity (deficit)		399,000		(3,000	)
Total liabilities and equity	$	1,149,000	$	970,000